Drawing for MYDATAHELPS

USPTO serial 98091841

MYDATAHELPS

Reviewed by CopyMark Law Group

Status 809Office Action
Filing date
Status date
Registration date
Examiner
RENNEKER, CHRISTOPHER JOHN
Law office
TMO LAW OFFICE 113

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Need help with MYDATAHELPS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Timothy M. McCarthy

Timothy M. McCarthy CLARK HILL PLC130 E. RANDOLPH ST., 39TH FL.CHICAGO, IL 60601United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software that provides real-time, integrated business management intelligence by combining information from various databases and presenting it in an easy-to-understand user interface; Downloadable computer application software for mobile phones, handheld computers, and desktop computers, namely, software for sharing the user's medical data among a plurality of providers; Downloadable software in the nature of a mobile application for sharing the user's medical data among a plurality of health care providersACTIVEDec 6, 2017
035Business information management, namely, electronic reporting of business information, business analytics, namely, business investigations, evaluations, expert appraisals, information and research, trade spend business management; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Collecting and analyzing claims data from healthcare organizations for business purposes; Consulting in the fields of healthcare operations management and hospital operations management; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of healthcare; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Providing business intelligence services; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciencesACTIVEDec 6, 2017
038Computer transmission of information accessed via a code or a terminal; Electronic data interchange (EDI) services; Electronic data interchange services in the field of electronic remittance advice, prior authorizations, attachments and referrals that allow direct transaction and payment communications between healthcare providers and payers; Electronic exchange of data stored in databases accessible via telecommunication networks; Electronic exchange of medical records across a nationwide health information network; Information transmission services via digital networks; Providing access to an electronic exchange of medical records across a nationwide health information networkACTIVEDec 6, 2017
044Healthcare; Healthcare services, namely, integrated healthcare services with a network of international healthcare providers; Providing healthcare informationACTIVEDec 6, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 29, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Jul 29, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 29, 2026CNFRSU - FINAL REFUSAL - WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 23, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 23, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 23, 2026ALIEASSIGNED TO LIE
Jul 23, 2026ALIEASSIGNED TO LIE
Jul 21, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 21, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 21, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 21, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 21, 2026CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 17, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE
Jan 10, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 7, 2025IUAFUSE AMENDMENT FILED
Jul 7, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 4, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 10, 2025EX1GSOU EXTENSION 1 GRANTED
Jan 9, 2025EXT1SOU EXTENSION 1 FILED
Jan 9, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 9, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 14, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 24, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2024XAECEXAMINER'S AMENDMENT ENTERED
Apr 5, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 5, 2024GNEAEXAMINERS AMENDMENT E-MAILED
Apr 5, 2024CNEAEXAMINERS AMENDMENT -WRITTEN
Mar 25, 2024DOCKASSIGNED TO EXAMINER
Aug 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2023NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance